Akero Therapeutics (AKRO) Q1 2026 Earnings

12MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1
-0.95
-0.91
-0.86

Details

Expected EPS
-1.001999
Actual EPS
N/A
Surprise EPS
1
Surprise Percent
+100%

Description

Akero Therapeutics (AKRO) will report earnings of for Q1 2026 on March 12, 2026.

0 Comments

Share your thoughts